Results 221 to 230 of about 5,552,271 (346)
ABSTRACT Objective Cognitive impairment, fatigue, and depression are common in multiple sclerosis (MS), potentially due to disruption of regional functional connectivity caused by white matter (WM) lesions. We explored whether WM lesions functionally connected to specific brain regions contribute to these MS‐related manifestations.
Alessandro Franceschini +7 more
wiley +1 more source
The Functional Neurological Disorder special collection in <i>Brain Communications</i>: bringing FND into the mainstream. [PDF]
Stone J.
europepmc +1 more source
Classifying eating disorders based on “healthy” and “unhealthy” perfectionism and impulsivity
M Landt +2 more
openalex +2 more sources
ABSTRACT Background Poststroke fatigue (PSF) and frailty share substantial overlap in their manifestations, yet previous research has yielded conflicting results due to the use of heterogeneous frailty assessment tools. Objective To evaluate the independent impact of frailty on PSF using a unified measurement system (Tilburg Frailty Indicator, TFI ...
Chuan‐Bang Chen +6 more
wiley +1 more source
Cultural aspects of anxiety disorders in India
Maherra Khambaty, Rajesh M. Parikh
openalex +1 more source
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin +12 more
wiley +1 more source
The Impact of Sleep Quality and Sleep Duration on Dietary Disorder: A Cross-Sectional Study in Xiamen, China. [PDF]
Tang H, Li K, Sun Q, Liu X.
europepmc +1 more source
Working Memory Deficits and its Relationship to Autism Spectrum Disorders.
Atusa Rabiee +4 more
openalex +2 more sources
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source

